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ft1C /L TH (MW. 303) CL1N. CHEM. 27/1, 10-13 (1981) Detection of Pentazocine and Tripelennamine in Urine Ralston W. Reid and Claire M. Gerbeck Pentazocine and tripelennamine can be identified in urine as a part of routine screening for drug abuse. Pentazocine, pentazocine hydrate, and tripelennamine can be detected by thin-layer chromatography of chloroform/isopropanol extracts of heat-and acid-hydrolyzed urine. Gas chromatography is used for confirmation. Gas chromatographic/ mass spectrometric studies (chemical ionization mode)
show that such extracts contain major molecular (M) ions of m/e 256, 286, and 304, indicating the presence of tnpelennamine, pentazocine, and pentazocine hydrate, respectively. pentazocine, and pentazocine hydrate are easily resolved under the conditions described above. The procedure involves simply taking a 2-iL aliquot of the previously prepared urine extract and injecting it onto the column. In about 6 mm the resolved peaks have appeared.
Although some other peaks do appear in the chromatogram, careful use of the proper standards allows one to confirm the presence or absence of the drugs of interest. Figure 1 shows g of ninhydrin (Fisher) in 100 mL of n-butanol (5). Store refrigerated and protected from light. lodoplatinate was prepared by adding 5 mL of a platinum (ic) chloride solution (100 g/L, Fisher) to 125 mL of 40 g/L potassium iodide and diluting to 250 mL with de-ionized water (6). Fluorescamine (Fluram; Roche Diagnostic Division of Hoffmann-La Roche, Inc., Nutley, NJ 07110) reagent was prepared by dissolving 10mg of Fluram in 100 mL of acetone (7).
Procedures

Routine thin-layer chromatography for drug screening
Extraction
and chromatography.
Mix a 10-mL aliquot of each urine with 2 mL of 6 mol/L HCI, hydrolyze by autoclaving for 30 mm at 103 kPa in a pressure cooker, cool, and transfer to a 50-mL screw-cap tube. Add a 5-mL aliquot of the same urine (unhydrolyzed) to this 50-mL tube to restore such heat-labile components as amphetamine. Add 2 mL of 6 mol/L NaOH and 5 mL of the borate buffer; the pH should be 9.0-9.3. Add 10 mL of chloroform/isopropanol (5/1 by vol), shake the mixture for 15 mm, centrifuge, and aspirate the upper (aqueous) layer. Transfer the remaining organic phase to a 16 X 125 mL glass tube and evaporate under air in a 50-55 #{176}C water bath. Dissolve each residue in 40 1zL of methanol and spot 30-40 1zL on a line drawn 2 cm from the bottom of the plate. On each plate, spot nine patients' samples and 5 to 10 L of a combined standard containing 1.0 g/L each of morphine, codeine, amphetamine, methamphetamine, quinine, meperidine, methadone, cocaine, propoxyphene, glutethimide, secobarbital, phenobarbital, and phenytoin (Gelman Sciences, Inc.). Spot the standard in the center position. Place the plate in a chromatography tank containing 100 mL of freshly prepared Solvent I and develop to a height of 6 cm from the origin. Remove the plate and thoroughly air-dry it in a fume hood. Place the plate in another chromatography tank containing 100 mL of freshly prepared Solvent II and develop to a height of 11 cm from the origin. Remove the plate and again thoroughly air-dry it in a fume hood. Table 2 ). The remaining residue can be used for gas-liquid chromatographic and (or) gas chromatographic/mass spectrometric verification procedures, when necessary. pentazocine, and pentazocine hydrate are easily resolved under the conditions described above. The procedure involves simply taking a 2-zL aliquot of the previously prepared urine extract and injecting it onto the column. In about 6 mm the resolved peaks have appeared.
Results
Although some other peaks do appear in the chromatogram, careful use of the proper standards allows one to confirm the presence or absence of the drugs of interest. Figure 1 shows typical chromatograms of the standards and of a drug abuser's urine extract. The peak appearing between pentazocine and pentazocine hydrate is typical, but is as yet unidentified.
Under the conditions des#{232}ribed, meperidine does not interfere because it is eluted with the solvent front.
The reconstructed ion current chromatogram of a drug abuser's urine extract, as seen on gas chromatography/mass spectrometry, is shown in Figure 2D . The scans that have been identified are those for pentazocine, tripelennamine, pentazocine hydrate, and some metabolites.
Tripelennamine, whose molecular ion is rn/e 256, is concentrated within scan 147 as shown in Figure 2A . The mass spectrum of scan 147 contains a molecular ion of rn/e 256, 38%; fragment ions of rn/e 211 (M-CH3NCH3), 100%; rn/c 254, 13%; and m/e 240 (M-CH3), 10%. All of these appear to be fragment ions of the tripelennamine molecule. Pentazocine, the other major drug in the extract, shows a molecular ion of rn/e 286 and is concentrated within scan 239 (Figure 213) , with a small amount present in scan 314. We believe the rn/e 286 ion at scan 314 is a fragment ion of 2'-hydroxy-2-(3-methyl-3-hydroxybutyl)-5,9-dimethyl-6,7-benzomorphan. were present in the chromatogram.
Peak 336, which follows the hydrated pentazocine, revealed large amounts of rn/c 255 ions, suggesting the presence of tripelennamine.
The base peak ion, rn/c 273, was also present in this scan. Finding this ion, which is 18 atomic mass units higher than that of tripelennamine (rn/c 255), and having found rn/c 255 as the major fragment in scan 336 suggests to us that the tripelennamine molecule, probably the pyridine ring, undergoes metabolic reduction and hydroxylation, and then, during mass spectrometry, the compound loses a water molecule, reverting to tripelennamine as a major fragment of hydrated tripelennamine. The first two peaks, rn/c 92 and 186 (shown in the chromatogram in Figure 2D) (13) reported that only 5 to 20% of pentazocine is excreted in the free form in the human urine, depending upon the subject and route of administration, the rest being excreted as conjugates of phenolic hydroxyl and isomeric alcohols derived from the cleaved dimethyl side chains. Thus, the use of acid hydrolysis not only will enhance the amount of the free drug but will also give the hydrated product, both of which can then be extracted and measured.
The specific thin-layer chromatographic procedure (Solvent III) that we describe for use in assay of pentazocine, pentazocine hydrate, and tripelennamine can easily be used by most laboratories involved in screening for drugs of abuse in urine.
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